Caremark says confidential information at risk in US FTC's insulin suit
MLex Summary: Caremark Rx told a US Federal Trade Commission administrative law judge that it will be prejudiced by the "significant time and expense" associated with protecting its confidential information from...To view the full article, register now.
Already a subscriber? Click here to view full article